grant

Regulation of Cadherins by MLK3

Organization UNIVERSITY OF TOLEDOLocation TOLEDO, UNITED STATESPosted 22 Sept 2023Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY2023ATP-protein phosphotransferaseAdherens JunctionAdhering JunctionAdhesionsAdhesive JunctionAnchoring JunctionBeta Cadherin-Associated ProteinBeta-1 CateninBiological FunctionBiological ProcessBody TissuesBreastCUL-2Cadherin-1CadherinsCancersCarcinomaCell AdhesionCell BodyCell JunctionsCell LocomotionCell MigrationCell MovementCell-Cell AdhesionCellsCellular AdhesionCellular MigrationCellular MotilityCo-ImmunoprecipitationsComplexDevelopmentE-CadherinEpithelial Calcium-Dependent Adhesion ProteinEpithelial CellsEpithelial cancerEpithelial-CadherinEpitheliumExperimental DesignsGene ExpressionGrowth Factor ReceptorsHumanIntercellular JunctionsInvadedKinase Family GeneKinasesMAP Kinase Kinase KinaseMAP kinaseMAP3 KinasesMAPKKKsMLK-3 proteinMMPsMacromolecular Protein ComplexesMalignant CellMalignant Epithelial NeoplasmsMalignant Epithelial TumorsMalignant NeoplasmsMalignant TumorMammalian CellMatrix MetalloproteinasesMediatingMerlinMesenchymalMitogen-Activated Protein Kinase Kinase KinasesMitogen-Activated Protein KinasesModern ManMoesin-Ezrin-Radixin-Like ProteinMorphogenesisMotilityMultiprotein ComplexesN-CadherinNF2NF2 Gene ProductNF2 geneNeurofibromatosis 2 Gene ProductNeurofibromatosis 2 GenesNeurofibromatosis Type 2 ProteinNeurofibromin 2OvarianOvarian TumorOvary NeoplasmsOvary TumorPRO2286PhosphorylationPhosphotransferase GenePhosphotransferasesProcessProliferatingProtein KinaseProtein PhosphorylationProteinsReceptor SignalingRegulationResearchRoleSchwannomerlinSchwannominSchwannomin ProteinShort interfering RNASignal PathwaySmall Interfering RNAStructureTestingTissuesTranscription RepressorTranscriptional RepressorTransphosphorylasesTumor CellUvomorulinbeta catenincancer cellcell motilitydevelopmentalepithelial carcinomagenetic repressorglycogen synthase a kinasehydroxyalkyl protein kinaseinsightknock-downknockdownmalignancymigrationmixed lineage kinase 3morphogenetic processneoplasm/cancerneoplastic cellnf 2 Genesnovelovarian neoplasmoverexpressoverexpressionphosphorylase b kinase kinaseprotein complexsiRNAslugsocial roleβ-catenin
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Mixed lineage kinase (MLK) 3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) that

regulates multiple MAPK signaling pathways in mammalian cells. In addition, MLK3 has been demonstrated to

regulate proliferation and invasion of different types of human epithelial cells (normal and cancer) including

ovarian and breast. In the current study, we identified a novel function for MLK3 in cell-cell adhesion of ovarian

epithelial TOV112D tumor cells. MLK3 siRNA knockdown disrupted cell-cell adhesion in TOV112D spheroids,

reduced the cell junction protein, E-cadherin, and dramatically increased the level of Slug, a transcriptional

repressor of E-cadherin. Furthermore, MLK3 was co-immunoprecipitated with E-cadherin in TOV112D cell

lysates, which indicates that MLK3 may be associated with adherens junction protein complexes. Additionally,

MLK3 overexpression induced the cleavage of E-cadherin resulting in an 80 kDa soluble form of E-cadherin,

which has been found to activate growth factor receptor signaling. In TOV112D cells, MLK3 overexpression

also strongly induced the expression of N-cadherin, a cell junction protein that is normally expressed in

mesenchymal cells. Our central hypothesis is that MLK3 regulates E-cadherin and N-cadherin through multiple

mechanisms, and this regulation is essential for proper cell adhesion and migration in ovarian epithelial cells.

The proposed experiments are designed to define the mechanism(s) by which MLK3 regulates E- and N-

cadherin, and the impact of this regulation on ovarian cell spheroid adhesion and migration. Three specific

aims are proposed to test the hypothesis. In Aim 1, we will investigate MLK3 functions in E-cadherin multi-

protein complexes and ovarian spheroid cell-cell adhesion. In aim 2, we will examine MLK3-dependent

regulation of Slug and E-cadherin expression. In Aim 3, we will evaluate MLK3-dependent regulation of E-

Cadherin cleavage, N-Cadherin expression and ovarian spheroid structure. This research will reveal novel

insight into the mechanisms by which MLK3 functions to regulate E- and N-cadherin and modulate cell-cell

adhesion and migration, processes which are essential for development, tissue morphogenesis, migration and

cancer cell invasion.

Grant Number: 1R15GM152942-01
NIH Institute/Center: NIH

Principal Investigator: Deborah Chadee

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →